Very happy with the Nabota! I started noticing results within about 2–4 days, and it worked exactly as expected. Fulfillment and shipping were also incredibly quick, which made the whole experience even better. Very satisfied with my purchase and would definitely order again.
고려제약(주)
티트로신겔(티로트리신) Infectious wound treatment
티트로신겔(티로트리신) Infectious wound treatment
No se pudo cargar la disponibilidad de retiro
■ Indications & Effects
(Main Use)
Helps improve superficial skin infections such as impetigo and folliculitis caused by susceptible strains of Trichophyton and Candida albicans.
■ Dosage & Administration
(Approved Label)
Apply a suitable amount to the affected area 1 to 3 times daily. For minor wounds or superficial infections, dressing is not necessary.
For more severe wounds or abrasions, dressing is recommended, and it is advised to change the dressing 1 to 2 times daily while applying the ointment.
■ Precautions for Use
Do not use this product in the following cases:
-
Individuals who:
-
Are allergic to any of the ingredients in this product
-
Have a history of hypersensitivity reactions to similar products
-
Have extensive or deep wounds
-
-
Pregnant or breastfeeding women (unless directed by a healthcare professional)
General Warnings:
-
Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
-
During use, if you experience any unusual symptoms such as itching, rash, or swelling, discontinue use and consult a doctor.
-
If using other topical medications, consult with a pharmacist or healthcare provider before combining treatments.
-
This product contains profenamine hydrochloride, so please consult your doctor before use if you have a history of hypersensitivity or are taking related medications.
Other Precautions:
-
Do not use this ointment in or around the eyes, mucous membranes, or on severely damaged skin unless directed.
-
Store in a cool, dry place away from direct sunlight.
-
Keep out of reach of children.
-
Do not transfer contents to another container.
-
Use within 3 months after opening.
Share
